Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1379239 | Bioorganic & Medicinal Chemistry Letters | 2006 | 5 Pages |
A series of monopyrrolinone-based HIV-1 protease inhibitors possessing rationally designed P2′ side chains have been synthesized and evaluated for activity against wild-type HIV-1 protease. The most potent inhibitor displays subnanomolar potency in vitro for the wild-type HIV-1 protease. Additionally, the monopyrrolinone inhibitors retain potency in cellular assays against clinically significant mutant forms of the virus. X-ray structures of these inhibitors bound in the wild-type enzyme reveal important insights into the observed biological activity.
Graphical abstractA series of monopyrrolinone-based HIV-1 protease inhibitors were synthesized and evaluated for activity against wild-type and mutant forms of the virus. X-ray cocrystal structures provide insight into their potent activity.Figure optionsDownload full-size imageDownload as PowerPoint slide